GRIDAI TECHNOLOGIES CORP.
Profile
Company Names
GRIDAI TECHNOLOGIES CORP.
ENTERO THERAPEUTICS, INC.
FIRST WAVE BIOPHARMA, INC.
AZURRX BIOPHARMA, INC.
BIOPHARMA D-AZUR, INC.
Addresses
433 PLAZA REAL, SUITE 275, BOCA RATON, FL 33432
79014TH ST N # 21135, ST. PETERSBURG, FL 33702
777 YAMATO ROAD, SUITE 502, BOCA RATON, FL 33431
777 YAMATO ROAD, SUITE 502, BOCA RATON, FL 33431
760 PARKSIDE AVE., SUITE 304, BROOKLYN, NY 11226
760 PARKSIDE AVENUE, SUITE 304, BROOKLYN, NY 11226
760 PARKSIDE AVENUE, DOWNSTATE BIOTECH. INCUBATOR SUITE 217, BROOKLYN, NY 11226
1410 BROADWAY, 23RD FLOOR, NEW YORK, NY 10018
Phone Numbers
561-589-7020
646-699-7855
(646) 699-7855
917-842-2353
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2014
State Incorporated:
DELAWARE
Total Amount Raised:
$58,151,484.00
Number of Funding Rounds:
16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2026-05-11
$5,250,000.00
$5,250,000.00
$0.00
Equity
15
2026-05-08
$2,540,000.00
$2,540,000.00
$0.00
Equity
14
2025-08-09
$3,025,000.00
$3,025,000.00
$0.00
13
2023-09-14
$1,470,509.00
$1,470,509.00
$0.00
12
2023-06-13
$431,083.00
$431,083.00
$0.00
11
2023-03-15
$4,000,001.00
$4,000,001.00
$0.00
Equity
10
2022-11-22
$2,500,001.00
$2,500,001.00
$0.00
Equity
9
2022-07-15
$300,000.00
$300,000.00
$0.00
Equity
8
2020-07-16
$22,426,890.00
$22,800,000.00
$373,110.00
Equity
7
2019-12-20
$6,904,000.00
$8,000,000.00
$1,096,000.00
Debt
6
2019-02-14
$2,000,000.00
$2,000,000.00
$0.00
Debt
5
2017-06-05
$5,000,000.00
$5,000,000.00
$0.00
Equity
4
2017-04-09
$1,000,000.00
$1,000,000.00
$0.00
Debt
3
2016-03-30
$635,000.00
$12,000,000.00
$11,365,000.00
Debt
2
2014-10-14
$284,000.00
$7,000,000.00
$6,716,000.00
Debt
1
2014-03-25
$385,000.00
$1,020,250.00
$635,250.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
EDWARD
BORKOWSKI
DIRECTOR
CHARLES
CASAMENTO
DIRECTOR
DAVID
HOFFMAN
DIRECTOR
NEXT BIG SOUND INC
| THRESHOLD PHARMACEUTICALS INC
| ZEBRA IMAGING INC
| EVENTSORBET, INC.
| FLYNTLOK, INC.
| HILDENE OPPORTUNITIES FUND LP
| HILDENE OPPORTUNITIES FUND II, L.P.
| FIRST WAVE BIO, INC.
| HILDENE CREDIT FUND, LP
| FIRST WAVE BIOPHARMA, INC.
| DELCATH SYSTEMS, INC.
| BVC DIGITAL OPPORTUNITIES I, LP
| MARKETSAI CORP.
RICHARD
PAOLONE
EXECUTIVE OFFICER, DIRECTOR
CHRISTINE
RIGBY
EXECUTIVE OFFICER
SARAH
ROMANO
EXECUTIVE OFFICER
JAMES
SAPIRSTEIN
EXECUTIVE OFFICER, DIRECTOR
JASON
SAWYER
DIRECTOR, EXECUTIVE OFFICER
MAGED
SHENOUDA
DIRECTOR, EXECUTIVE OFFICER
JOHAN
M.
SPOOR
EXECUTIVE OFFICER, DIRECTOR
JOHAN (THIJS)
SPOOR
DIRECTOR, EXECUTIVE OFFICER
JACK
SYAGE
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-05-11
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-05-08
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-03-15
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-11-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-07-15
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-07-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-06-05
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2016-03-30

